A lower dose of this COVID-19 drug is effective, Yale study finds
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases...
Will we have another COVID-19 surge this spring?
COVID-19 cases and hospitalizations remain low in Chicago and in other parts of the country, but cases are rising in parts of Europe and...
As the BA.2 variant circulates, will you need a second COVID-19 booster?
As the BA.2 variant of the coronavirus gains traction around the world, you may be wondering whether you’ll need a second COVID-19 booster shot.
While...
This new COVID-19 vaccine could prevent future infectious diseases
A new study from Northwestern University found just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in...
Aspirin may improve survival for people with severe COVID-19
A new study from Imperial College London found antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19,...
Saliva COVID-19 test is quicker, safer than nasal swabs
In a new study from the University of Maryland, researchers found genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing...
This new oral drug may prevent death from COVID-19
The immune system deteriorates with age, making COVID-19 particularly deadly in older people—but to date, no clinically available medication addresses this key risk factor.
A...
Scientists find a universal antibody therapy for all COVID-19 variants
In a new study from the University of Alabama at Birmingham, researchers discovered a monoclonal antibody that potentially acts as a potent universal coronavirus...
This new PCR test can detect all COVID-19 variants
In a new study from Rutgers University and elsewhere, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection,...
Fourth COVID vaccine shot for Omicron cannot benefit these people
In a new study from the Sheba Medical Center, researchers found the fourth dose of existing mRNA COVID-19 vaccines offer little benefit to younger...